In vitro capacity of different grades of chitosan derivatives to induce platelet adhesion and aggregation
Highlights
► Chitosan. ► Platelet adhesion. ► Platelet count. ► Morphology. ► Platelet aggregation.
Introduction
Since the middle of World War II, half of recorded combat deaths have occurred due to exsanguinating hemorrhage. A military post-mortem study of casualties in Operation Iraqi Freedom (OIF) suggested that up to 24% of all battlefield mortality could be reduced with improved anti-hemorrhaging methods and that 85% of deaths were caused by uncontrolled hemorrhage [1]. The development of new methods or devices for hemorrhage control may contribute to a future reduction in hemorrhage morbidity and mortality [2]. Recently, chitosan-derived antihemorrhage biomaterial, which contains N-acetyl glucosamine (found abundantly as a major component in shells of arthropods such as crabs, shrimps, lobsters and insects) [3] was identified as having potential clinical utility.
Chitosan has become one of the most promising local hemostatic agents. It is of particular importance as it functions independently on platelets and normal clotting mechanisms. Chitosan derivatives also possesses amino and hydroxyl groups that permit them to be chemically adjusted by processes such as acylation, N-phthaloylation, alkylation, Schiff base formation, reductive alkylation, tosylation, O-carboxymethylation, N-carboxyalkylation, and graft copolymerization [4], [5]. Although there are numerous studies on the hemostatic capacity of chitosan, to the best of our knowledge there are a limited numbers of in vitro studies on the capacity of chitosan derivatives acting on platelets as an absorbable surgical hemostatic agent. Driven by the significant role of adherence in platelet response during the hemostasis process, in our present study we conducted platelet adhesion and aggregation tests to characterize platelet capacity in the presence of chitosan.
The major functions of platelets in hemostasis involve their adherence at the sites of vessel injury, activation of internal signaling pathways, and formation of plugs by aggregation and clumping [6]. For platelet aggregation, we have added an ADP agonist to induce chitosan-adhered platelets. We used N,O-carboxymethylchitosan (NO-CMC), O-carboxymethylchitosan (O-CMC) and Oligo-chitosan (O-C), produced by Standard and Industrial Research Institute of Malaysia (SIRIM Berhad), with a degree of deacetylation of 75–98%. Lyostypt®, a commercial hemostatic agent was used as a positive control. Our results show that platelets respond differently to the presence of chitosan derivatives with differing molecular weights and degrees of deacetylation.
Section snippets
Different grades and forms of chitosan
In this study, different percentage levels of chitosan sponges and two distinct powdered types of chitosan were used. The following sponge forms were used: 2% NO-CMC, 7% NO-CMC (with 0.45 mL collagen), 8% NO-CMC, O-C 52, and 5% O-CMC-47. The powdered forms of chitosan were NO-CMC-35 and O-C 53.
Subjects
Blood was withdrawn from antecubital veins and collected in vials containing 3.8% sodium citrate. We recruited 30 healthy donors aged 18–40 who had not consumed drugs in the previous two weeks. Informed
Platelet count
Fig. 1 showing the most significant increase from the baseline 297.3 ± 47.19 × 103/μL was observed for O-C 52: 248.6 ± 42.20 × 103/μL after 10 min and 221 ± 41.07 × 103/μL after 20 min. The percentage of platelet counts decreased slightly from the baseline (25.66%) over the 20 min (16.38%) time interval. The next largest increase was observed for O-C 53. The percentage change in the platelet count increased from 11.86% to 17.82%. Table 1 pointing the analysis of correlation indicated that the relationships
Conclusion
Chitosan derivatives exert a combined effect on thrombogenesis by causing platelets to aggregate and form pseudopodal shapes. Various formulations of chitosan exhibited different capabilities in vitro based on the chemical composition of the material. We conclude that O-C 52 and O-C 53 were superior to other types of chitosan in achieving hemostasis. Further studies are needed to elucidate the precise mechanism of action of chitosan derivatives on platelets.
Acknowledgements
This project is funded by USM Short term grant 304/PPSP/61310037. We thank all the donors who participated in this study.
References (31)
- et al.
Journal of Surgical Research
(1996) - et al.
Carbohydrate Polymers
(2003) - et al.
Biomaterials
(1997) - et al.
Biomaterials
(1998) Blood
(1999)- et al.
Biochemical and Biophysical Research Communications
(2003) - et al.
Biochemical and Biophysical Research Communications
(1996) - et al.
Journal of Trauma
(2008) - et al.
Journal of Trauma
(2003) Nutrition Research
(1998)
Journal of Biomaterials Applications
Trends in Glycoscience and Glycotechnology
American Journal of Clinical Pathology
Journal of Nano Research
Cited by (23)
Chitosan: A review of molecular structure, bioactivities and interactions with the human body and micro-organisms
2022, Carbohydrate PolymersCitation Excerpt :This general correlation can be explained by the molecular chain configuration model, which is the general mechanism of interactions between chitosan and organisms, such as mammalian cells and microbes, as discussed earlier. When interacting with blood, chitosan and its derivatives have been reported to enhance blood coagulation, and to cause the aggregation of both platelets and erythrocytes (Okamoto et al., 2003), even though the precise mechanism is not clearly understood (Periayah et al., 2013). Sagnella and Mai-Ngam (2005) found that the platelet adhesion is due to the positive charge on chitosan as a polycationic polymer, and that the increase of the adhesion is correlated positively with the increase in the magnitude of the positive charge.
Chitin-based nanomaterials
2021, Biopolymeric Nanomaterials: Fundamentals and ApplicationsChitin, chitosan, and their derivatives
2021, Nutraceuticals: Efficacy, Safety and ToxicityNatural polymers
2019, Biomaterials for Skin Repair and RegenerationEfficacy of chitosan derivative films versus hydrocolloid dressing on superficial wounds
2018, Journal of Taibah University Medical SciencesDifferent chemical groups modification on the surface of chitosan nonwoven dressing and the hemostatic properties
2018, International Journal of Biological Macromolecules